51 Firmen mit Ergebnissen für "怎么查酒店开房信息- 查询微信1 37"

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

837 Ergebnisse für "怎么查酒店开房信息- 查询微信1 37" unter University Hospital Zurich​, Research and Education Office

Slide A IV 37

... fibromatosis ICD-10: M72.9; ICD-O: 8822/ 1 A IV 37 Frau, 34 J., harter Knoten unter der ... Slide A IV 37 Fibromatose fibromatosis HE fibromatosis ICD-10: M72.9; ICD-O: 8822/ 1 A IV 37 Frau ... Slide A IV 37 ... Slide A IV 37 ...

Slide A III 37

... ICD-10: I12 A III 37 Mann, 73 J., arterielle, "essentielle" Hypertonie; verstirbt an ... Slide A III 37 ... Slide A III 37 Arteriolosklerose der Niere arteriolosclerosis of kidney SFOG arteriolosclerosis of ... Slide A III 37 ...

Mehr Ergebnisse

CSL Vifor

https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor  

8952 Schlieren, Zürcherstrasse 39D

 +41 58 851 80 00

Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.

CSL Vifor

Zürcherstrasse 39D

8952 Schlieren

497 Ergebnisse für "怎么查酒店开房信息- 查询微信1 37" unter CSL Vifor

CSL Annual Report 2023 – Page 37

... 1 36 Table of Contents 38 172 CSL Annual Report 2023 CSL Limited Annual Report 2022/23 35 CSL’s R&D ... CSL Annual Report 2023 – Page 37 1 36 Table of Contents 38 172 CSL Annual Report 2023 CSL Limited ... CSL Annual Report 2023 – Page 37 ... CSL Annual Report 2023 – Page 37 ...

CSL Annual Report 2022 – Page 37

... 1 36 Table of Contents 38 156 CSL Annual Report 2022 CSL Limited Annual Report 2021/22 35 New ... CSL Annual Report 2022 – Page 37 1 36 Table of Contents 38 156 CSL Annual Report 2022 CSL Limited ... CSL Annual Report 2022 – Page 37 ... CSL Annual Report 2022 – Page 37 ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

10621 Ergebnisse für "怎么查酒店开房信息- 查询微信1 37" unter University of Zurich

“Israel” in the Joseph Story (Genesis 37–50) - Zurich Open Reposito...

... “Israel” in the Joseph Story (Genesis 37–50) Schmid, Konrad (2017). “Israel” in the Joseph Story ... (Genesis 37–50). In: Lipschitz, Oded ; Gadot, Yuval ; Adams, Matthew J. . Rethinking Israel. Studies in the ... “Israel” in the Joseph Story (Genesis 37–50) - Zurich Open Repository and Archive ... “Israel” in the Joseph Story (Genesis 37–50) - Zurich Open Repository and Archive Header ... “Israel” in the Joseph Story (Genesis 37–50) - Zurich Open Repository and Archive ...

UZH - Department of Geography - #37: Was machen Geographinnen und G...

... 21 Apr 2020 # 37: Was machen Geographinnen und Geographen nach dem Studium? Breites theoretisches ... UZH - Department of Geography - # 37: Was machen Geographinnen und Geographen nach dem Studium? ... UZH - Department of Geography - # 37: Was machen Geographinnen und Geographen nach dem Studium? Home ... UZH - Department of Geography - # 37: Was machen Geographinnen und Geographen nach dem Studium? ...

Mehr Ergebnisse

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

19367 Ergebnisse für "怎么查酒店开房信息- 查询微信1 37" unter Somagenetix

A Better Solution for the Text of Xenophon, Symp. 4. 37 - Zurich Op...

... A Better Solution for the Text of Xenophon, Symp. 4. 37 Cooper, Guy L (1971). A Better Solution for ... the Text of Xenophon, Symp. 4. 37. Classical Quarterly, 21(01):62. Copy Abstract IT may be taken as a ... A Better Solution for the Text of Xenophon, Symp. 4. 37 - Zurich Open Repository and Archive ... A Better Solution for the Text of Xenophon, Symp. 4. 37 - Zurich Open Repository and Archive Header ... A Better Solution for the Text of Xenophon, Symp. 4. 37 - Zurich Open Repository and Archive ...

Late manifestation of dyskeratosis congenita presenting as chronic ...

... dyskeratosis congenita presenting as chronic dermal ulcer in a 37-year-old man. Journal of the European Academy ... Late manifestation of dyskeratosis congenita presenting as chronic dermal ulcer in a 37-year-old ... Late manifestation of dyskeratosis congenita presenting as chronic dermal ulcer in a 37-year-old ... Late manifestation of dyskeratosis congenita presenting as chronic dermal ulcer in a 37-year-old ...

Mehr Ergebnisse

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

8418 Ergebnisse für "怎么查酒店开房信息- 查询微信1 37" unter ETH Entrepreneurship

Slide 1

... Height - 10mm Fin Length - CSPI = 37 W/(dm3.K) - 1.5mm Baseplate ■ Two-Side Cooling  Heatsink ... Slide 1 1/5 Fraza d.o.o. ■ Compliant to All Original LBC Specifications (!) - No Low-Frequ. CM ... Height - 10mm Fin Length - CSPI = 37 W/(dm3.K) - 1.5mm Baseplate ■ Two-Side Cooling  Heatsink ... Slide 1 ... Slide 1 ...

Slide 1

... . Performance Index - 200um Fin Thickness - 500um Fin Spacing - 3mm Fin Height - 10mm Fin Length - CSPI = 37 W ... / <10ns Delay - TCM Current / Induced Voltage / Comparator Output 37/69 Power Pulsation Buffer Capacitor ... . Performance Index - 200um Fin Thickness - 500um Fin Spacing - 3mm Fin Height - 10mm Fin Length - CSPI = 37 W ... / <10ns Delay - TCM Current / Induced Voltage / Comparator Output 37/69 Power Pulsation Buffer Capacitor ... Slide 1 ...

Mehr Ergebnisse

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

304 Ergebnisse für "怎么查酒店开房信息- 查询微信1 37" unter Blutspende SRK Zürich

Folie 1

... anti-Jka. The newborn showed no clinical signs of HDFN. Figure 1: positive (3+) crossmatch (IAT, 37°C ... , Cressier, CH and in-house). Crossmatches were carried out by indirect antiglobulin test (IAT) at 37°C ... anti-Jka. The newborn showed no clinical signs of HDFN. Figure 1: positive (3+) crossmatch (IAT, 37°C ... , Cressier, CH and in-house). Crossmatches were carried out by indirect antiglobulin test (IAT) at 37°C ... Folie 1 ...

Folie 1

... applicable 37 bp insertion RH1 negative (frameshift and premature stopcodon) frameshift stop RH1 negative ... Folie 1 RHD DONOR SCREENING IN SWITZERLAND: RESOLVING NOVEL ALLELES BY NANOPORE-SEQUENCING S ... applicable 37 bp insertion RH1 negative (frameshift and premature stopcodon) frameshift stop RH1 negative ... Folie 1 ... Folie 1 ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

2486 Ergebnisse für "怎么查酒店开房信息- 查询微信1 37" unter Roche Glycart AG

OP-EHEA190412 1..61

... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 9 Pulmonary embolism and pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 9.2 Diagnosis of pulmonary embolism in pregnancy . . . . . . . . . . . . . . . 37 9.2.1 Clinical ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 9 Pulmonary embolism and pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 9.2 Diagnosis of pulmonary embolism in pregnancy . . . . . . . . . . . . . . . 37 9.2.1 Clinical ... OP-EHEA190412 1..61 ...

腫瘍微小環境 | ロシュ・ダイアグノスティックス

... of the PD-L1/PD- 1 pathway to T-cell exhaustion: an update on implications for chronic infections and ... 腫瘍 小環境 | ロシュ・ダイアグノスティックス ... 腫瘍 小環境 | ロシュ・ダイアグノスティックス あなたはこのサイト上での十分な体験を阻害しうる匿名/プライベートブラウジングモードもしくは広告除去ソフトを使用しているようです。広告除去ソフトを無効 ... 腫瘍 小環境 | ロシュ・ダイアグノスティックス ...

Mehr Ergebnisse

InSphero AG

http://www.insphero.com  

8952 Schlieren, Wagistrasse 27

 +41 44 515049-0
 info@insphero.com

InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.

InSphero AG

Wagistrasse 27

8952 Schlieren

280 Ergebnisse für "怎么查酒店开房信息- 查询微信1 37" unter InSphero AG

Slide 1

... Slide 1 1 1 0 1 0 0 1 0 0 0 0 5 0 1 0 0 1 5 0 2 0 0 S ita x s e n ta n (µ M ) C e ll v ia b il it y ... 0 = M4 32 .8 IC 5 0 = M1 90 .9 IC 5 0 = M3 48 . 1 H u m a n H e p /H u m a n N P C 1 1 0 1 0 0 1 0 ... Slide 1 1 1 0 1 0 0 1 0 0 0 0 5 0 1 0 0 1 5 0 2 0 0 S ita x s e n ta n (µ M ) C e ll v ia b il it y ... 0 = M4 32 .8 IC 5 0 = M1 90 .9 IC 5 0 = M3 48 . 1 H u m a n H e p /H u m a n N P C 1 1 0 1 0 0 1 0 ... Slide 1 ...

Folie 1

... Folie 1 INTRODUCTION Defeating the animal: Alternative systems for neurotoxicity testing Julia ... Leist2, Christoph van Thriel1 1 IfADo, Dortmund, Germany 2 University of Konstanz, Konstanz, Germany 3 ... Folie 1 INTRODUCTION Defeating the animal: Alternative systems for neurotoxicity testing Julia ... Leist2, Christoph van Thriel1 1 IfADo, Dortmund, Germany 2 University of Konstanz, Konstanz, Germany 3 ... Folie 1 ...

Mehr Ergebnisse

Repertoire Immune Medicines (Switzerland) AG

https://www.repertoire.com/  

8952 Schlieren, Wagistrasse 27


 info@repertoire.com

The key to our strategy lies in understanding the inner workings of the immune synapse – the interaction between the T cell and the antigen presenting cell which dictates the immune code that tells a T cell to become toxic and to kill the infected tissue. Our scientists created and developed the DECODETM and DEPLOY suite of technologies, which allows in-depth characterization of TCR-antigen pairings – and the ability to rationally design and clinically develop targeted immune medicines. Our scientists also have developed novel technologies that attach potent immunomodulators to T cells, enabling us to deliver potent cytokines such as IL-15 or IL-12 directly to tumors by using the natural homing power of the T cells to traffic to diseased tissue.

Repertoire Immune Medicines (Switzerland) AG

Wagistrasse 27

8952 Schlieren

25 Ergebnisse für "怎么查酒店开房信息- 查询微信1 37" unter Repertoire Immune Medicines (Switzerland) AG

Repertoire Immune Medicines Launches Type 1 Diabetes Focused Progra...

... current Flagship ecosystem comprises 37 transformative companies, including: Axcella Health (NADAQ: AXLA ... 1 Diabetes CAMBRIDGE AND BOSTON, MA – March 25, 2020 – Repertoire Immune Medicines, a newly launched ... 37 transformative companies, including: Axcella Health (NADAQ: AXLA), Denali Therapeutics (NASDAQ ... Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D ... Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D ...

Flagship Pioneering Announces the Launch of Repertoire Immune Medic...

... follow-on investments from other institutions. The current Flagship ecosystem comprises 37 transformative ... follow-on investments from other institutions. The current Flagship ecosystem comprises 37 transformative ...

Mehr Ergebnisse

Kuros Biosciences AG

https://kurosbio.com/  

8952 Schlieren, Wagistrasse 25

 +41 (0)44 733 4747

Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Kuros Biosciences AG

Wagistrasse 25

8952 Schlieren

126 Ergebnisse für "怎么查酒店开房信息- 查询微信1 37" unter Kuros Biosciences AG

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs M...

... . 2021; 41:756-73. 3.    Duan, et al. eCM. 2019; 37:60-73. 4.    Van Dijk, et al. Clin Spine Surg ...  MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft Schlieren (Zurich ... . 2021; 41:756-73. 3.    Duan, et al. eCM. 2019; 37:60-73. 4.    Van Dijk, et al. Clin Spine Surg ... Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in ... Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in ...

Comments on: Kuros Biosciences completes enrolment in Level 1 clini...

... Comments on: Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules ... Comments on: Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules ... Comments on: Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules ... https://kurosbio.com/resources/kuros-biosciences-completes-enrolment-in-level- 1-clinical-study-of ... Comments on: Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules ...

Mehr Ergebnisse

Mehr Firmen

Nach oben